Table 1.

Comparison of clinical characteristics between the remission and nonremission groups during IT and at 1-year follow-up

Variable	Total	Remission group	Nonremission group	P
n	48	21	27
Sex
Male	34	15	19
Female	14	6	8
Age (years)	50.6 ± 7.9	49.4 ± 8.8	51.5 ± 7.1	0.376
BMI (kg/m2)
Before therapy	25.7 ± 3.3	26.3 ± 3.8	25.3 ± 2.9	0.326
After therapy	25.6 ± 3.1	26.0 ± 3.3	25.2 ± 2.9	0.393
At 1 year	25.2 ± 3.3	25.2 ± 3.5	25.2 ± 3.2	0.974
FPG (mmol/L)
Before therapy	11.5 ± 2.8	11.7 ± 2.9	11.7 ± 2.4	0.993
After therapy	7.5 ± 2.1*	6.2 ± 0.8*	8.5 ± 2.2*	0.000
At 1 year	6.8 ± 1.4*	6.3 ± 1.3*	7.5 ± 1.4*	0.011
PPG (mmol/L)
Before therapy	14.8 ± 5.8	15.1 ± 6.9	14.5 ± 4.9	0.721
After therapy	7.6 ± 3.1*	6.1 ± 1.5*	8.8 ± 3.4*	0.002
At 1 year	7.7 ± 2.7*	6.5 ± 1.78*	9.2 ± 2.9*	0.001
TG (mmol/L)
Before therapy	2.0 ± 1.0	1.7 ± 0.5	2.2 ± 1.3	0.073
After therapy	1.5 ± 0.8*	1.2 ± 0.4*	1.7 ± 1.0*	0.040
At 1 year	1.6 ± 0.7†	1.5 ± 0.7‡	1.6 ± 0.8†	0.751
TC (mmol/L)
Before therapy	5.0 ± 1.0	4.9 ± 1.0	5.1 ± 0.9	0.442
After therapy	4.6 ± 0.9*	4.5 ± 0.9	4.7 ± 0.8†	0.601
At 1 year	4.9 ± 0.9	4.7 ± 0.8‡	5.2 ± 0.9§	0.047
HDL (mmol/L)
Before therapy	1.2 ± 0.3	1.2 ± 0.2	1.2 ± 0.3	0.578
After therapy	1.3 ± 0.3*	1.2 ± 0.3†	1.3 ± 0.4†	0.515
At 1 year	1.3 ± 0.4	1.2 ± 0.2	1.4 ± 0.5	0.189
LDL (mmol/L)
Before therapy	3.0 ± 0.8	3.2 ± 0.8	3.0 ± 0.8	0.408
After therapy	2.7 ± 0.8*	2.8 ± 0.7†	2.6 ± 0.8*	0.345
At 1 year	2.8 ± 0.8*	2.8 ± 0.7*	2.9 ± 0.9	0.850
FFA (mmol/L)
Before therapy	0.7 ± 0.3	0.7 ± 0.3	0.7 ± 0.2	0.462
After therapy	0.7 ± 0.2	0.7 ± 0.2	0.6 ± 0.2	0.745
A1C (%)
Before therapy	10.0 ± 2.2	10.5 ± 2.3	9.7 ± 2.0	0.184
After therapy	7.9 ± 1.5*	8.1 ± 1.6*	7.7 ± 1.4*	0.357
At 1 year	6.5 ± 0.7*§	6.2 ± 0.7*§	6.8 ± 0.6*	0.004

Categorical data are expressed as number and continuous data as means ± SD. P value for remission vs. nonremission group.

*P < 0.01 vs. before therapy.

†P < 0.05 vs. before therapy.

‡P < 0.05 vs. after therapy.

§P < 0.01 vs. after therapy.